ATROPINE SULFATE (nda020056)- (EQ 0.36MG BASE/INH)

Generic Name	ATROPINE SULFATE	Innovator	US ARMY
Dosage	EQ 0.36MG BASE/INH
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	Atropine is an anti-muscarinic agent indicated for:  Cycloplegia  Mydriasis  Penalization of the healthy eye in the treatment of amblyopia.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 0.36MG BASE/INH	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of ATROPINE SULFATE